The Gabelli Healthcare & Wellness Trust
GRX
New York Stock Exchange- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Wayne Christopher Pinsent
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- One Corporate Center Rye NY United States of America 10580-1422
- IPO Date
- Jun 19, 2007
- CIK
- 0001391437
- Website
- gabelli.com
- Similar Companies
- Business
- The Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) is a diversified, closed-end management investment company whose primary investment objective is long-term growth of capital by investing at least 80% of its assets, under normal market conditions, in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries; these investments span pharmaceuticals (such as AbbVie Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., and Merck & Co Inc.), health care providers and services (such as Tenet Healthcare Corp., Option Care Health Inc., and Cencora Inc.), health care equipment and supplies (such as Halozyme Therapeutics Inc.), and related sectors including food products (such as Post Holdings Inc.). The Fund operates globally, with a portfolio including holdings across various market capitalizations in the United States and international markets. Launched in 2007 and managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc., the Trust is headquartered in Rye, New York, with its investment team led by Chairman and Chief Investment Officer Mario J. Gabelli, CFA, Co-CIO of Value Kevin Dreyer, and sector-focused analysts covering pharmaceuticals, insurance, value-based care, and life sciences. In recent developments, the Fund declared its fourth quarter 2025 distribution of $0.17 per share in November 2025, estimated to comprise 5% net investment income, 88% net capital gains, and 7% return of capital, subject to year-end finalization; additionally, Director Mario J. Gabelli purchased 2,500 common shares on December 3, 2025, at $9.6877 per share, increasing his direct holdings to 239,425 shares while maintaining indirect ownership through entities such as GGCP, Inc. and Associated Capital Group, Inc. The portfolio benefited from robust merger and acquisition activity among smaller holdings, including Silk Road Medical, Stericycle, and others, amid trends like elevated hospital admissions impacting insurers such as Elevance, UnitedHealth, and CVS Health; top contributors during recent periods included Tenet Healthcare Corp. and BellRing Brands. With total net assets of approximately $215 million as of late 2025, the Fund maintains a net expense ratio of 1.3% (excluding preferred share distributions) and trades at a market price reflecting leverage to enhance returns in the growing health and wellness sector valued over $1.5 trillion.